Amy J Galliher

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. pmc Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells
    Amy J Galliher
    UCHSC, Fitzsimons Campus, Department of Pharmacology, Mail Stop 8303, RC1 South Tower, Rm L18 6110, PO Box 6511, Aurora, CO 80045, USA
    Breast Cancer Res 8:R42. 2006
  2. ncbi Role of transforming growth factor-beta in cancer progression
    Amy J Galliher
    University of Colorado Health Sciences Center, Department of Pharmacology, Aurora, Colorado 80045, USA
    Future Oncol 2:743-63. 2006
  3. ncbi Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion
    Amy J Galliher
    Department of Pharmacology, University of Colorado Health Sciences Center, 12801 East 17th Avenue, Aurora, CO 80045, USA
    Cancer Res 67:3752-8. 2007
  4. ncbi TGF-beta in cancer and other diseases
    Jason R Neil
    Department of Pharmacology, University of Colorado Health Sciences Center, Aurora, Colorado 80206, USA
    Future Oncol 2:185-9. 2006

Collaborators

Detail Information

Publications4

  1. pmc Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells
    Amy J Galliher
    UCHSC, Fitzsimons Campus, Department of Pharmacology, Mail Stop 8303, RC1 South Tower, Rm L18 6110, PO Box 6511, Aurora, CO 80045, USA
    Breast Cancer Res 8:R42. 2006
    ..The molecular mechanisms underlying this conversion of TGF-beta function remain poorly understood but may involve signaling inputs from integrins...
  2. ncbi Role of transforming growth factor-beta in cancer progression
    Amy J Galliher
    University of Colorado Health Sciences Center, Department of Pharmacology, Aurora, Colorado 80045, USA
    Future Oncol 2:743-63. 2006
    ....
  3. ncbi Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion
    Amy J Galliher
    Department of Pharmacology, University of Colorado Health Sciences Center, 12801 East 17th Avenue, Aurora, CO 80045, USA
    Cancer Res 67:3752-8. 2007
    ....
  4. ncbi TGF-beta in cancer and other diseases
    Jason R Neil
    Department of Pharmacology, University of Colorado Health Sciences Center, Aurora, Colorado 80206, USA
    Future Oncol 2:185-9. 2006